Last updated: 2026-09-10 08:35:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Biote Corp. (BTMD) operates in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector and is listed on NASDAQ. The stock is currently priced at $1,39, with a market capitalization of $43,30M and a P/E ratio of 7,10. Over the past 52 weeks, its price has ranged from $1,27 to $3,54. This page covers its latest market performance, valuation, price trends and company information.
$43,30M | |
$1,45 | |
$10,51 | |
$1,27 | |
$1,45 | |
-- | |
317,67K | |
7,10 | |
$3,54 | |
$1,27 | |
2,81% | |
-- |
Biote Corp. (BTMD) is trading at $1,39 in pre-market trading as of 2026-09-10 08:10:00, down 4,41% ($0,06) from the previous close of $1,45
Pre-market trading shows how investors are pricing BTMD before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, Biote Corp. (BTMD) moved from $1,64 to $1,39, representing a decline of 15,49% ($0,25).
The stock traded between $1,39 and $1,80 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 276,70 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 5,1%
BTMD is currently trading at $1,39, placing it 5,1% of the way from its 52-week low of $1,27 to its 52-week high of $3,54. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
| Industry | MEDICINAL CHEMICALS & BOTANICAL PRODUCTS |
| Employees | 223 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Biote Corp. (BTMD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.